Project Grant HT94252510078
Award Date
3/1/25
Completion Date
2/29/28
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cold Spring Harbor, NY 11724, USA
Similar Awards
The U.S. Department of the Army Medical Command awarded a $518,342 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Cold Spring Harbor Laboratory (CSHL) for a 3-year period from July 1, 2025 to June 30, 2028. The grant supports research investigating "Communication Between Cancer-Associated Fibroblasts and Neurons Promotes Pancreatic Cancer Progression." CSHL, a non-profit research institution, will conduct advanced scientific investigations...
The Department of Defense's Defense Health Agency has awarded a $1,344,002 Project Grant to Cold Spring Harbor Laboratory (CSHL) under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, running from August 1, 2024 to July 31, 2028, will fund research to enhance immunity in colorectal cancer liver metastases. CSHL, a renowned non-profit research institution, will leverage its expertise in cancer biology, genomics, and molecular biology to advance this...
The Department of the Army Medical Command awarded a $384,001 Project Grant to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2022 to February 29, 2024 to investigate the neural circuit mechanisms of stress-induced insomnia and metabolic dysfunction. Through its support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The Department of the Army Medical Command awarded $1,394,002 to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2022 for a project grant with a completion date of August 14, 2025. Under this award, Cold Spring Harbor Laboratory and sub-awardees Weill Medical College of Cornell University will explore the relationship between sites of metastatic prostate cancer and the peripheral nerve system. Researchers will analyze human...
The U.S. Department of Defense's Defense Health Agency awarded a $384,000 Project Grant to the Cold Spring Harbor Laboratory (CSHL) to study the impact of recurrent acute pancreatitis on macrophage heterogeneity and function. This grant, awarded under the Military Medical Research and Development program (CFDA 12.420), will fund research aimed at improving the health and care of military service members, veterans, and their families. The grant has a performance period from February 1, 2024 to...
This federal Project Grant award, valued at $728,450.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to support research conducted by the Cold Spring Harbor Laboratory (CSHL) in Cold Spring Harbor, NY. The purpose of the award is to investigate "COMMUNICATION BETWEEN CANCER-ASSOCIATED FIBROBLASTS AND NEURONS PROMOTES PANCREATIC CANCER PROGRESSION", with a performance period from July 1, 2025 through June 30, 2028....
The Department of the Army Medical Command awarded a $576,001 Project Grant to Cold Spring Harbor Laboratory to support research titled "Role of the Tumor Neuroenvironment in Prostate Cancer Metastasis." The two-year award running from August 1, 2022 to July 31, 2024 will fund research investigating the role of the tumor microenvironment in prostate cancer metastasis. This award is being made under the Military Medical Research and Development program (CFDA 12.420). This program...
The U.S. Department of the Army Medical Command awarded The Trustees of Columbia University in the City of New York a $197,400 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on February 15, 2025, supports the "Development of Patient-Derived CNS Metastasis Models with STK11 Inactivation for Drug Discovery". The research aims to develop innovative patient-derived models of central nervous system (CNS) metastases...
The Department of the Army Medical Command awarded a $1,419,356 project grant to Brigham & Women's Hospital Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop novel immunotherapy approaches to suppress cancer metastasis and recurrence in bone. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The federal Project Grant award of $1,224,997.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cold Spring Harbor Laboratory (CSHL) to conduct research aimed at "ENHANCING IMMUNITY IN COLORECTAL CANCER LIVER METASTASES." This grant, with a performance period from August 1, 2024 to July 31, 2028, will allow CSHL, a renowned non-profit research institution, to leverage its expertise in cancer biology, genomics,...